Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Bio-Works Technologies

1.63

 

SEK

 

+1.87 %

Less than 1K followers

BIOWKS

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Compare
+1.87%
+23.02%
+29.65%
+69.26%
+91.79%
+0.3%
-87.84%
-69.01%
-81.03%

Bio-Works Technologies is a biotechnology company. The company develops products that separate and purify molecules in the production of drugs. The technology is based on chromatography that aims to handle the drug substance. Customers are found in the European market where products are sold through distribution partners and to companies in the pharmaceutical industry. They are also sold to research institutes and universities. The company was founded in 2006 and is headquartered in Uppsala.

Read more
Market cap
128.34M SEK
Turnover
217.2K SEK
Revenue
25.47M
EBIT %
-149.2 %
P/E
-
Dividend yield-%
-
Financial calendar
22/8
2025

Interim report Q2'25

20/2
2026

Annual report '25

All
Press releases
3rd party
ShowingAll content types
Regulatory press release5/16/2025, 1:09 PM

Bio-Works Technologies AB: Correction to press release sent our yesterday

Bio-Works Technologies
Regulatory press release5/16/2025, 1:09 PM

Bio-Works Technologies AB: Rättelse till press meddelande från i går

Bio-Works Technologies
Regulatory press release5/15/2025, 1:02 PM

Bio-Works Technologies AB: Bio-Works erhåller order på WorkBeads värd 2,5 miljoner kronor

Bio-Works Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/15/2025, 1:02 PM

Bio-Works Technologies AB: Bio-Works receives WorkBeads order worth SEK 2.5 million

Bio-Works Technologies
Regulatory press release5/15/2025, 8:30 AM

Bio-Works Technologies AB: Resolutions passed at Bio-Works Technologies' annual general meeting 2025

Bio-Works Technologies
Regulatory press release5/15/2025, 8:30 AM

Bio-Works Technologies AB: Kommuniké från Bio-Works Technologies årsstämma 2025

Bio-Works Technologies
Regulatory press release5/15/2025, 5:00 AM

Bio-Works Technologies AB: Bio-Works rapporterar första kvartalet 2025

Bio-Works Technologies
Regulatory press release5/15/2025, 5:00 AM

Bio-Works Technologies AB: Bio-Works reports first quarter 2025

Bio-Works Technologies
Regulatory press release4/29/2025, 2:04 PM

Bio-Works Technologies AB: Bio-Works Receives Order Worth SEK 2.4 Million from New European Customer in Vaccine Production

Bio-Works Technologies
Regulatory press release4/29/2025, 2:04 PM

Bio-Works Technologies AB: Bio-Works erhåller order om 2,4 MSEK från ny europeisk kund inom vaccinproduktion

Bio-Works Technologies
Regulatory press release4/15/2025, 3:00 PM

Bio-Works Technologies AB meddelar utfall från inlösen av teckningsoptioner av serie TO 2. Nyttjandeperiod 2 av 11

Bio-Works Technologies
Regulatory press release4/15/2025, 3:00 PM

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 2 of 11

Bio-Works Technologies
Regulatory press release4/14/2025, 2:27 PM

Bio-Works Technologies AB: Bio-Works receives SEK 12 million order from global pharmaceutical company - delivery scheduled for 2026

Bio-Works Technologies
Regulatory press release4/14/2025, 2:27 PM

Bio-Works Technologies AB: Bio-Works erhåller order på 12 MSEK från globalt läkemedelsföretag - leverans planerad till 2026

Bio-Works Technologies
Regulatory press release4/11/2025, 12:00 PM

Bio-Works Technologies AB: Bio-Works publicerar årsredovisningen 2024

Bio-Works Technologies
Regulatory press release4/11/2025, 11:00 AM

Bio-Works Technologies AB: Kallelse till årsstämma i Bio-Works Technologies

Bio-Works Technologies
Regulatory press release4/1/2025, 6:00 AM

Idag inleds den andra nyttjandeperioden för Bio-Works Technologies AB:s teckningsoptioner av serie TO 2

Bio-Works Technologies
Regulatory press release4/1/2025, 6:00 AM

Today is the first day of the second exercise period for Bio-Works Technologies AB's warrants of series TO 2

Bio-Works Technologies
Regulatory press release3/27/2025, 3:02 PM

Bio-Works Technologies AB: Bio-Works Receives New Orders for Custom GoBio Columns for the U.S. Gene Therapy Market

Bio-Works Technologies
Regulatory press release3/27/2025, 3:02 PM

Bio-Works Technologies AB: Bio-Works får nya order på specialanpassad GoBio kolonner till det amerikanske genterapimarknad

Bio-Works Technologies
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team